Sour OspA Grapes & Guidelines from Valhella (Shhhh! IDSA sekritt!)

[Mort Zuckerman]

To: bpc...@norwichdiocese.net, scientifi...@ostp.gov,
pkru...@princeton.edu, Stanle...@fiu.edu,
emcsw...@niaid.nih.gov, afa...@niaid.nih.gov,
Spin...@yahoogroups.com, kshe...@calea.org, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
michae...@po.state.ct.us, con...@po.state.ct.us, executive-
edi...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, biz...@nytimes.com, for...@nytimes.com,
nati...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, illino...@aol.com, jle...@courant.com,
tinaj...@yahoo.com, jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@po.state.ct.us, kur...@washpost.com,
georg...@washpost.com, p...@allegorypress.com,
commissi...@po.state.ct.us, brans...@comcast.net,
vts...@comcast.net, o...@po.state.ct.us, freet...@charter.net,
scott....@po.state.ct.us, govern...@po.state.ct.us,
attorney...@po.state.ct.us, randall...@usdoj.gov,
Robert....@yale.edu, edi...@greenwich-post.com,
harol...@yale.edu, sedm...@nswbc.org, rrmcg...@aol.com
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, afa...@niaid.nih.gov,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, amcg...@rms-law.com, rjmu...@aol.com,
paulcrai...@yahoo.com, sidney_b...@yahoo.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
christophe...@usdoj.gov, richar...@yale.edu,
harol...@yale.edu, james.p...@yale.edu, inq...@aldf.com,
ly...@idsociety.org, meganm...@theatlantic.com,
bob.d...@latimes.com

Subject: Sour OspA Grapes & Guidelines from Valhella (Shhhh! IDSA
sekritt!)

Date: Jun 13, 2009 8:23 AM


OSP A and CROOKED SOUR GRAPES

2000, Gary Wormser on OspA causing immunosuppression while LYMErix was
still on the market:
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=10865170[uid]

Modulation of lymphocyte proliferative responses by a canine Lyme
disease vaccine of recombinant outer surface protein A (OspA).

“OspA interferes with the response of lymphocytes to proliferative
stimuli including a blocking of cell cycle phase progression. Future
studies designed to delete the particular region or component of the
OspA molecule responsible for this effect may lead to improved vaccine
preparations.”


Oh. OspA doesn’t do the usual thing vaccines do. One would think
that would be something looked at during the vaccine trials, but no.
They had Arthur Weinstein in charge of Data Safety for the Sigal-
Barbour ImmuLyme vaccine ***“ - a claim not supported by the data
here:”***
http://www.journals.uchicago.edu/doi/pdf/10.1086/313920?cookieSet=1

Get that now?

Using the Dearborn Method, which in 1993 Gary Wormser said was only
15% accurate (detected 9 out of 59 cases)…:
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=266355&blobtype=pdf

…Lenny Sigal using the Dearborn Method with MarDx Western Blot strips
found ImmuLyme to be 92% “safe and effective” (while unable to read
his blots):
Dearborn/MarDx
http://content.nejm.org/cgi/content/abstract/339/4/216
Can’t read the blots:
http://www.journals.uchicago.edu/doi/pdf/10.1086/313920?cookieSet=1


Lenny Sigal, says he could not read his Dearborn Western Blots in the
OspA-ImmuLyme trial, but Lenny’s ImmuLyme gang objects to the Yale
LYMErix gang doing the exact same thing to qualify their OspA vaccine:
http://www.actionlyme.org/DICKSON_FDA_SUBMISSION_FULL.htm
Yale-LYMErix-OspA bad Blot readers!!:
http://content.nejm.org/cgi/content/abstract/339/4/209

‘▲Same type of vaccine trial - OspA, same diagnostic criteria
(Dearborn), same company’s Western Blot strips (MarDx), but one team
(ImmuLyme-OspA) claims the other (LYMErix-OspA) committed a crime and
could not read their Western Blots:
http://www.journals.uchicago.edu/doi/pdf/10.1086/313920

“The manufacturer of the only currently FDA approved
(and released) recombinant OspA Lyme disease vaccine
has suggested that vaccination does not interfere with serological
evaluation of Lyme disease in vaccine recipients―a
statement that is not supported by the data presented here.”


LMAO.

And Gary Wormser claims that OspA interferes with normal lymphocyte
function in 2000.

One would think vaccine trials would be set up around collecting data
about the immune response generated from the vaccine, since that’s
what vaccines are for.

http://www.actionlyme.org/WEINSTEINIUM.htm

-----------------

Guidelines from Valhella

IDSA GUIDELINES AUTHORS:
http://www.journals.uchicago.edu/doi/full/10.1086/508667
Gary P. Wormser,1 Raymond J. Dattwyler,2 Eugene D. Shapiro,5,6 John J.
Halperin,3,4 Allen C. Steere,9 Mark S. Klempner,10 Peter J. Krause,8
Johan S. Bakken,11 Franc Strle,13 Gerold Stanek,14 Linda Bockenstedt,7
Durland Fish,6 J. Stephen Dumler,12 and Robert B. Nadelman1

“There is no convincing biologic evidence for the existence of
symptomatic chronic B. burgdorferi infection among patients after
receipt of recommended treatment regimens for Lyme disease.”

"Except the following reports by ourselves (and don’t forget, we’re
playing a shell game with the DNA and RNA primers; we only use the
correct ones when we want to find spirochetes in ticks):
http://www.actionlyme.org/PRIMERSHELLGAME.htm

"Don’t tell nobody a boud how Borrelia are categorized by differences
in their flagellin:
http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=138

"IDSA sekritt!!

Steere, 1992, when in Europe to falsify the (Dearborn) standard:
”These strains were characterized as high-passage Borrelia burgdorferi
by Marconi at the Rocky Mountain Bioweapons Lab in Montana using the
16S RNA method:”
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=1370282
http://www.actionlyme.org/STEERE_IN_EUROPE.htm

Schoen, 1995:
http://jcm.asm.org/cgi/reprint/35/1/233?view=long&pmid=8968914

Wormser, 1992:
http://jcm.asm.org/cgi/reprint/30/12/3082?view=long&pmid=1452688
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=9986813[uid]

Nobody tells Mark Klempner that these are the primers to use to find
Lyme in humans:
http://content.nejm.org/cgi/content/full/345/2/85
But he threw the DNA positive cases out right at the beginning of the
speriment anyway. Shh!

[It’s part of the Negative Data Rule which states: Do not use the
correct lab techniques if they might produce data you don’t like, and
especially, pretend you are not aware of the previous methods that you
have used.]

==============================

IDSA’s Treatment Failure Reports

Allen Steere on treatment failure (1/3 of the cases were positive even
with the bogus OspA primers):
http://www.annals.org/cgi/content/full/121/8/560

Allen Steere on treatment failure:
http://www.annals.org/cgi/content/full/121/8/560

CDC Officer Alan Barbour on antibiotic treatment failure:
”When using Borrelia to cure Syphilis, we recommend using high
passage strains:”
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=373079&blobtype=pdf

Allen Steere on treatment failure:
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=8769624[uid]

Mark Klempner on ceftriaxone’s failure to kill intracellular
spirochetes:
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=1634816[uid]

Alan Barbour on treatment failure, especially as regards spirochetes
in the brain:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=8913478

Yale Pathology Department on treatment failure of the pregnant,
seronegative mother:
http://www.actionlyme.org/Congenital_Brain_Infection_of_Newborn_Resulting_in_Death.htm

CDC, SUNY-SB, the Mayo Clinic and Tulane all participate in the
Liegner Autopsies and find persisting spirochetes (DNA or staining)
after multiple courses of treatment:
http://www.actionlyme.org/CDC_Spirochetes_Brain_Liegner_Autopsy.htm

All the known worldwide experts gathered in 1975 to talk about
spirochetal diseases:
http://www.actionlyme.org/Biology_of_Parasitic_Spirochetes1976.htm
"The ability of the borrelia, especially tick-borne strains to persist
in the brain and in the eye after treatment with arsenic or with
penicillin or even after apparent cure is well known (1). The
persistence of treponemes after treatment of syphilis is a major area
which currently requires additional study (3,5,10,11)."

IDSA’s Russell Johnson who wrote the book about the above 1975
conference:
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=4,721,617.PN.&OS=PN/4,721,617&RS=PN/4,721,617
"The chronic forms of the disease such as arthritis (joint
involvement), acrodermatitis chronica atrophicans (skin involvement),
and Bannwart's syndrome (neurological involvement) may last for months
to years and are ***associated with the persistence of the
spirochete.*** A case of maternal-fetal transmission of B. burgdorferi
resulting in neonatal death has been reported. Domestic animals such
as the dog also develop arthritis and lameness to this tick-borne
infection. For every symptomatic infection, there is at least one
asymptomatic infection. Lyme disease is presently the most commonly
reported tick-borne disease in the United States." --

The patent also says:

"The infection may be treated at any time with antibiotics such as
penicillin, erythromycin, tetracycline, and ceftriaxone. ***Once
infection has occurred, however, the drugs may not purge the host of
the spirochete but may only act to control the chronic forms of the
disease.*** Complications such as arthritis and fatigue may continue
for several years after diagnosis and treatment."

IDSA on the Treatment of Syphilis:
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=2682964[uid]
"Recent evaluations of ceftriaxone for early syphilis therapy are
promising; however, the optimal dose and duration of therapy are
unknown."
http://www.actionlyme.org/IDSA_TMTSYPHILIS.htm


And this list does not include all the older data about how
spirochetal diseases are incurable:
http://www.actionlyme.org/RICOCHRON.htm



"[Real] scientists are *fiercely* independent. That's the good
news."-- NIH's Top Fool, Anthony Fauci